Journal
NATURE COMMUNICATIONS
Volume 9, Issue -, Pages -Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/s41467-018-06187-0
Keywords
-
Categories
Funding
- Ministry of Education, Culture, Sports, Science and Technology and Astellas Pharma, Inc.
- JSPS KAKENHI Grant [JP16K15663]
Ask authors/readers for more resources
In human inflammatory sites, PD-1(hi)CXCR5(-)CD4(+) T cells are involved in the formation of ectopic lymphoid-like structures (ELSs) by the secretion of chemokine CXCL13, but how the transcription of CXCL13 is regulated in CD4(+) T cells is still unclear. Here we show that Sox4 is a key transcription factor for CXCL13 production in human CD4(+) T cells under inflammatory conditions. In vitro TGF-beta(+), IL-2-neutralizing culture conditions give rise to PD-1(hi)CXCR5(-)CD4(+) T cells that preferentially express CXCL13, and transcriptome analysis and lentiviral overexpression indicate Sox4 association with the CXCL13 transcription. In vivo, Sox4 is significantly upregulated in synovial CD4(+) T cells, when compared with blood CD4(+) T cells, from patients with rheumatoid arthritis (RA), and further correlates with ELS formation in RA synovium. Overall, our studies suggest that Sox4 contributes to CXCL13 production and ELS formation at inflammatory sites in humans.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available